Drugs for Posterior Uveitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 99)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Methylprednisolone |
Approved, Vet_approved |
Phase 4 |
|
83-43-2 |
6741 |
Synonyms:
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
1-dehydro-6alpha-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6a-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6-alpha-Methylprednisolone
6a-Methyl-11b,17a,21-triol-1,4-pregnadiene-3,20-dione
6-Methylprednisolone
6α-methyl-11β,17α,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-wyeth
Artisone-Wyeth
Besonia
Bio-0658
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
delta(1)-6alpha-Methylhydrocortisone
Delta(1)-6alpha-Methylhydrocortisone
delta(1)-6a-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
Lemod
LMST02030178
LS-118498
M0639_SIGMA
M1665
Medesone
Medixon
Medlone 21
Medrate
Medric acid
|
Medrol
Medrol (TN)
Medrol adt pak
Medrol Adt Pak
Medrol dosepak
Medrol Dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
MEPRDL
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
methylprednisolone
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
methylprenisolone
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [Dcit]
Metilprednisolone [DCIT]
Metipred
Metrisone
Metrocort
Metysolon
MLS000028541
MLS001148159
MLS002207191
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
Nirypan
Noretona
NSC19987
NSC-19987
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick_622
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Promacortine
Reactenol
S1733_Selleck
SAM002589984
Sieropresol
SMR000058330
Solomet
SPBio_002377
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
δ(1)-6a-methylhydrocortisone
δ(1)-6α-methylhydrocortisone
|
|
2 |
|
Prednisolone phosphate |
Approved, Vet_approved |
Phase 4 |
|
302-25-0 |
|
Synonyms:
Prednisolone 21-(dihydrogen phosphate)
Prednisolone 21-monophosphate
|
Prednisolone 21-phosphate
|
|
3 |
|
Methylprednisolone hemisuccinate |
Approved |
Phase 4 |
|
2921-57-5 |
|
Synonyms:
Methylprednisolone hydrogen succinate
|
Methylprednisolone succinate
|
|
4 |
|
Prednisolone acetate |
Approved, Vet_approved |
Phase 4 |
|
52-21-1 |
|
5 |
|
Prednisolone |
Approved, Vet_approved |
Phase 4 |
|
50-24-8 |
5755 |
Synonyms:
(11b)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11b,17a,21-triol-3,20-dione
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11b,17a,21-triol
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1,4-pregnadiene-3,20-dione-11β,17α,21-triol
1,4-Pregnadiene-3,20-dione-11β,17α,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11b,17a,21-Trihydroxy-1,4-pregnadiene
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
3,20-dioxo-11β,17α,21-trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
Bio-0666
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
Codelcortone
Co-Hydeltra
CO-Hydeltra
component of Ataraxoid
component of K-Predne-Dome
Cordrol
Cortalone
Cotogesic
Cotolone
CPD000718761
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
delta(1)-Cortisol
delta(1)-Dehydrocortisol
Delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
Delta(1)-dehydrohydrocortisone
Delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
Delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Deltacortenol
Deltacortril
Deltacortril Enteric
delta-dehydrocortisol
delta-dehydrohydrocortisone
Delta-Ef-Cortelan
delta-hydrocortisone
Deltahydrocortisone
Deltasolone
Delta-stab
Delta-Stab
Deltisilone
Depo-Medrol
Derpo Pd
Derpo PD
Dexa-Cortidelt hostacortin H
Dexa-Cortidelt Hostacortin H
Di adreson F
Di Adreson F
Di-adreson F
Di-Adreson F
Di-adreson-F
DiAdresonF
Di-Adreson-F
Dicortol
Donisolone
Dydeltrone
Eazolin D
Econopred
Econopred Plus
EINECS 200-021-7
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
Hostacortin H
HSDB 3385
Hydeltra
Hydeltrasol
Hydeltra-Tba
Hydeltrone
|
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
Inflamase Forte
Inflamase Mild
I-Pred
K 1557
Key-Pred
Klismacort
Lentosone
Lite Pred
LMST02030179
LS-7669
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone acetate
Methylprednisolone Acetate
Meticortelone
Meti-Derm
Metreton
MLS001304083
MLS002154250
MLS002207037
MolPort-002-507-147
M-Predrol
NCGC00179649-01
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
NSC 9120
NSC9120
NSC9900
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
PRDL
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
PRED-G
Predisolone sodium phosphate
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Prednicen
Predni-Dome
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
prednisolone
Prednisolone
Prednisolone (anhydrous)
Prednisolone (JP15/USP/INN)
Prednisolone [INN:BAN:JAN]
Prednisolone acetate
Prednisolone Acetate
Prednisolone sodium phosphate
Prednisolone Sodium Phosphate
Prednisolone tebutate
Prednisolone Tebutate
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick_404
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Rolisone
S1737_Selleck
SAM002264639
Scherisolon
SMR000718761
Solone
SPBio_002367
Steran
Sterane
Sterolone
Supercortisol
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-hydrogen
Ultracortene-Hydrogen
UNII-9PHQ9Y1OLM
ZINC03833821
δ(1)-dehydrocortisol
δ(1)-dehydrohydrocortisone
δ(1)-hydrocortisone
|
|
6 |
|
Chlorambucil |
Approved |
Phase 4 |
|
305-03-3 |
2708 |
Synonyms:
23125_FLUKA
305-03-3
4-(Bis(2-chloroethyl)amino)benzenebutanoic acid
4-(P-Bis(b-chloroethyl)aminophenyl)butyrate
4-(P-Bis(b-chloroethyl)aminophenyl)butyric acid
4-(P-Bis(beta-chloroethyl)aminophenyl)butyrate
4-(p-bis(beta-chloroethyl)aminophenyl)butyric acid
4-(P-Bis(beta-chloroethyl)aminophenyl)butyric acid
4-(P-Bis(β-chloroethyl)aminophenyl)butyrate
4-(p-bis(β-chloroethyl)aminophenyl)butyric acid
4-(P-Bis(β-chloroethyl)aminophenyl)butyric acid
4-[P-[Bis(2-chloroethyl)amino]phenyl]butyrate
4-[p-[bis(2-chloroethyl)amino]phenyl]butyric acid
4-[P-[Bis(2-chloroethyl)amino]phenyl]butyric acid
AB00051938
AC1L1EAB
AC1Q75DO
AI3-26083
Ambochlorin
Amboclorin
BPBio1_001208
BRD-K29458283-001-05-9
BRN 0999011
BSPBio_001098
BSPBio_001971
C 0253
C0253_SIGMA
C14H19Cl2NO2
CAS-305-03-3
CB 1348
Cb l348
CB1348
CB-1348
CCRIS 126
CHEBI:28830
CHEMBL515
Chlocambucil
Chloorambucol
chlorambucil
Chlorambucil
Chlorambucil (USP/INN)
Chlorambucil [INN:BAN]
Chlorambucilum
Chlorambucilum [INN-Latin]
Chloraminophen
Chloraminophene
Chlorbutin
Chlorbutine
Chlorbutinum
Chloroambucil
Chlorobutin
Chlorobutine
CID2708
Clorambucile
Clorambucile [DCIT]
Clorambucilo
Clorambucilo [INN-Spanish]
CPD000058372
D00266
D002699
DB00291
DivK1c_000688
Ecloril
EINECS 206-162-0
Elcoril
Elcorin
EU-0100227
FT-0083565
g-[P-Di(2-chloroethyl)aminophenyl]butyrate
g-[P-Di(2-chloroethyl)aminophenyl]butyric acid
gamma-[P-Di(2-chloroethyl)aminophenyl]butyrate
gamma-[p-di(2-chloroethyl)aminophenyl]butyric acid
gamma-[P-Di(2-chloroethyl)aminophenyl]butyric acid
glaxo Wellcome brand OF chlorambucil
Glaxo Wellcome Brand of Chlorambucil
GlaxoSmithKline brand OF chlorambucil
GlaxoSmithKline Brand of Chlorambucil
HMS1571G20
HMS1920M15
HMS2090M19
HMS2091A22
HMS502C10
HSDB 3026
IDI1_000688
|
KBio1_000688
KBio2_000558
KBio2_003126
KBio2_005694
KBio3_001191
KBioGR_000766
KBioSS_000558
Leuk ersan
Leukeran
LEUKERAN (TN)
Leukeran tablets
Leukeran Tablets
Leukersan
Leukoran
Linfolizin
Linfolysin
Lopac0_000227
Lopac-C-0253
LS-1158
Lympholysin
MLS000028443
MLS001076130
MolPort-000-152-694
N,N-Di-(2-chloroethyl)-P-aminophenylbutyric acid
N,N-Di-2-chloroethyl-gamma-P-aminophenylbutyrate
N,N-di-2-chloroethyl-gamma-p-aminophenylbutyric acid
N,N-Di-2-chloroethyl-gamma-P-aminophenylbutyric acid
N,N-Di-2-chloroethyl-g-P-aminophenylbutyrate
N,N-Di-2-chloroethyl-g-P-aminophenylbutyric acid
N,N-Di-2-chloroethyl-γ-P-aminophenylbutyrate
N,N-di-2-chloroethyl-γ-p-aminophenylbutyric acid
N,N-Di-2-chloroethyl-γ-P-aminophenylbutyric acid
NCGC00015199-01
NCGC00015199-02
NCGC00015199-03
NCGC00015199-07
NCGC00015199-14
NCGC00023250-00
NCGC00023250-03
NCGC00023250-04
NCGC00023250-05
NCGC00023250-06
NCGC00023250-07
NCGC00023250-08
NCGC00023250-09
NCGC00023250-10
NCI60_002639
NCI-C03485
NINDS_000688
NSC 3088
NSC3088
NSC-3088
Pepstatin
Phenylbuttersaeure-lost
Phenylbuttersaeure-lost [German]
Phenylbutyrate nitrogen mustard
Phenylbutyric acid nitrogen mustard
Phenylbutyric Acid Nitrogen Mustard
Prestwick0_001079
Prestwick1_001079
Prestwick2_001079
Prestwick3_001079
RCRA waste no. U035
Rcra waste number U035
SAM002564202
SMR000058372
SPBio_000249
SPBio_002999
Spectrum_000118
SPECTRUM1500171
Spectrum2_000065
Spectrum3_000336
Spectrum4_000273
Spectrum5_000677
ST50410766
TL8002353
UNII-18D0SL7309
Wellcome brand OF chlorambucil
Wellcome Brand of Chlorambucil
WLN: QV3R DN2G2G
γ-[P-di(2-chloroethyl)aminophenyl]butyrate
γ-[p-di(2-chloroethyl)aminophenyl]butyric acid
γ-[P-di(2-chloroethyl)aminophenyl]butyric acid
|
|
7 |
|
Mycophenolic acid |
Approved |
Phase 4 |
|
24280-93-1 |
446541 |
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acid, mycophenolic
Acide mycophenolique
acido Micofenolico
Acido micofenolico
Acidum mycophenolicum
Melbex
|
micofenolico acido
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolic acid
Mycophenolsaeure
Mycophenolsäure
Myfortic
|
|
8 |
|
Tacrolimus |
Approved, Investigational |
Phase 4 |
|
104987-11-3 |
445643 439492 6473866 |
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
Advagraf
AKOS005145901
Ambap104987-11-3
Ambap5429
Anhydrous tacrolimus
Anhydrous, tacrolimus
BCBcMAP01_000194
Bio-0921
Bio2_000470
Bio2_000950
BRD-K35452788-001-02-1
BSPBio_001279
BSPBio-001279
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
Cilag brand OF tacrolimus
CPD000466356
CPD-10016
D08556
DB00864
DivK1c_001040
FK 506
FK5
Fk-506
FK506
FK-506
FR 900506
FR900506
|
FR-900506
FT-0082660
Fujimycin
Fujisawa brand OF tacrolimus
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
IDI1_001040
IDI1_002225
Janssen brand OF tacrolimus
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
nchembio.2007.23-comp2
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Prograft
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
tacrolimus
Tacrolimus
Tacrolimus (anhydrous)
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus anhydrous
tacrolimus hydrate
Tacrolimus, anhydrous
Tsukubaenolide
UNII-Y5L2157C4J
|
|
9 |
|
Cyclophosphamide |
Approved, Investigational |
Phase 4 |
|
50-18-0, 6055-19-2 |
2907 |
Synonyms:
(-)-Cyclophosphamide
(+-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
Anhydrous cyclophosphamide
Anhydrous, cyclophosphamide
ASTA
Asta B 518
ASTA B518
B 518
B-518
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
BRN 0011744
BSPBio_002099
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
CID2907
Clafen
Claphene
CP
CPA
CTX
CY
Cycloblastin
Cyclophosphamid
cyclophosphamide
Cyclophosphamide
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide anhydrous
Cyclophosphamide monohydrate
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide, (+-)-Isomer
Cyclophosphamide, (R)-isomer
Cyclophosphamide, (S)-isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
|
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
DB00531
DivK1c_000246
EINECS 200-015-4
Endoxan
Endoxan R
Endoxana
Endoxanal
Endoxan-Asta
Endoxane
Enduxan
EU-0100238
Genoxal
Hexadrin
HMS2090A12
HSDB 3047
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
Lopac0_000238
Lopac-C-0768
LS-1302
LS-99787
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
Monohydrate, cyclophosphamide
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI60_002097
NCI-C04900
Neosar
NINDS_000246
NSC 26271
NSC26271
NSC-26271
NSC273033
NSC273034
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra waste number U058
Rcra Waste Number U058
Revimmune
S1217_Selleck
Semdoxan
Sendoxan
Senduxan
SK 20501
SPBio_001071
Spectrum_000858
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
STK177249
STOCK2S-91217
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
|
|
10 |
|
Azathioprine |
Approved |
Phase 4 |
|
446-86-6 |
2265 |
Synonyms:
[Methyl(nitroimidazolyl)mercaptopurine]
446-86-6
55774-33-9 (hydrochloride salt)
6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine
6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine
6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine
6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine
6-(1-Methyl-4-nitroimidazol-5-ylthio)purin
6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech]
6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine
6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine
6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine
6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine
6-(Methyl-p-nitro-5-imidazolyl)thiopurine
6-(Methyl-p-nitro-5-imidazolyl)-thiopurine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine
6-[(1-Methyl-4-nitroimidazol-5-yl)- thio] purine
6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine
6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine
A 4638
A2593_SIAL
A4638_SIAL
A4638_SIGMA
AB00443544
AB00443544-03
AC1L1DAL
AC1Q3Z1F
AC-4230
AI3-50290
AI-981/34845012
Azamun
Azamun [Czech]
Azanin
Azasan
Azasan (TN)
Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine
Azathioprin
azathioprine
Azathioprine
Azathioprine (JP15/USP/INN)
Azathioprine [USAN:INN:BAN:JAN]
Azathioprine sodium
Azathioprine Sodium
Azathioprine sodium salt
Azathioprine sulfate
Azathioprinum
Azathioprinum [INN-Latin]
Azathiopurine
azatiopr in
Azatioprin
Azatioprina
Azatioprina [INN-Spanish]
Azothioprine
B. W. 57-322
BPBio1_000054
BRD-K32821942-001-05-6
BRD-K60324116-001-01-5
BSPBio_000048
BSPBio_001876
BW 57322
BW 57-322
BW-57-322
C06837
C9H7N7O2S
CAS-446-86-6
CBDivE_013132
CCRIS 62
Ccucol
CHEBI:2948
CHEMBL1542
ChemDiv1_002659
CID2265
cMAP_000046
CPD000427366
Cytostatics
D00238
DB00993
DivK1c_000586
|
EINECS 207-175-4
EU-0100027
FT-0083532
HMS1568C10
HMS1920E17
HMS2091K19
HMS501N08
HMS594I19
HSDB 7084
IDI1_000586
Immuran
Imuran
Imuran (TN)
Imurek
Imurel
KBio1_000586
KBio2_000464
KBio2_002427
KBio2_003032
KBio2_004995
KBio2_005600
KBio2_007563
KBio3_001376
KBio3_002906
KBioGR_000646
KBioGR_002427
KBioSS_000464
KBioSS_002433
Lopac0_000027
Lopac-A-4638
LS-123
Methylnitroimidazolylmercaptopurine
MLS001049307
MolPort-000-745-914
MolPort-000-764-262
MolPort-003-665-485
Muran
NCGC00015060-01
NCGC00015060-02
NCGC00015060-04
NCGC00015060-12
NCGC00090836-01
NCGC00090836-02
NCGC00090836-03
NCGC00090836-04
NCGC00090836-05
NCGC00090836-06
NCGC00094593-01
NCGC00094593-02
NCGC00094593-03
NCI-C03474
NINDS_000586
NSC 39084
NSC39084
NSC-39084
Oprea1_375441
Oprea1_533384
Oprea1_633462
Prestwick_41
Prestwick0_000094
Prestwick1_000094
Prestwick2_000094
Prestwick3_000094
S1721_Selleck
SAM002589938
SDCCGMLS-0065415.P001
SMR000427366
Sodium, azathioprine
SPBio_000255
SPBio_001987
Spectrum_000064
SPECTRUM1500133
Spectrum2_000068
Spectrum3_000308
Spectrum4_000243
Spectrum5_000848
STK831906
STOCK1S-20293
STOCK1S-27186
Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl)
UNII-MRK240IY2L
WLN: T56 BM DN FN HNJ IS- ET5N CNJ A1 DNW
ZINC04258316
|
|
11 |
|
Infliximab |
Approved |
Phase 4 |
|
170277-31-3 |
|
Synonyms:
Ig gamma-1 chain C region
Infliximab (genetical recombination)
Infliximab-abda
Infliximab-axxq
|
Infliximab-dyyb
Infliximab-qbtx
Remicade
|
|
12 |
|
Ranibizumab |
Approved |
Phase 4 |
|
347396-82-1 |
459903 |
Synonyms:
347396-82-1
D05697
Lucentis
Lucentis (TN)
ranibizumab
|
Ranibizumab
Ranibizumab (genetical recombination)
Ranibizumab (genetical recombination) (JAN)
Ranibizumab (USAN/INN)
rhuFab V2
|
|
13 |
|
Tretinoin |
Approved, Investigational, Nutraceutical |
Phase 4 |
|
302-79-4 |
444795 5538 |
Synonyms:
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate
(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate
(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
.beta.-Retinoic acid
[3H]Retinoic acid
13497-05-7 (hydrochloride salt)
15-Apo-beta-caroten-15-oic acid
187175-63-9
1n4h
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoate (ecl)
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ECL)
302-79-4
5300-03-8
56573-65-0
7005-78-9
9(Z)-Retinoic acid
9-cis-RA
A-Acido (Argentina)
Aberel
Aberela
Aberela [Norway]
AC1L9GWO
AC1Q1J2J
AC-6824
Accutane Roche
Acid A Vit (Belgium, Netherlands)
Acid, all-trans-retinoic
Acid, all-trans-Retinoic
Acid, beta-all-trans-retinoic
Acid, beta-all-trans-Retinoic
Acid, retinoic
Acid, Retinoic
Acid, trans-retinoic
Acid, trans-Retinoic
Acid, vitamin a
Acid, Vitamin A
Acide retinoique
Acide retinoique (French) (DSL)
Acnavit
Acnavit [Denmark]
AGN 100335
AGN 192013
Airol
Aknefug
Aknoten
AKOS000280845
Alitretinoin
all trans Retinoic acid
All Trans Retinoic Acid
all trans-Retinoic acid
All Trans-Retinoic Acid
all-(e)-Retinoate
all-(e)-Retinoic acid
all-(E)-Retinoic acid
All-trans Retinoic Acid
all-trans-beta-Retinoate
all-trans-beta-Retinoic acid
all-trans-b-Retinoate
all-trans-b-Retinoic acid
all-trans-Retinoic acid
Alltrans-retinoic acid
all-trans-Tretinoin
all-trans-Vitamin a acid
all-trans-Vitamin A acid
all-trans-Vitamin a1 acid
all-trans-Vitamin A1 acid
all-trans-β-retinoate
all-trans-β-retinoic acid
ALRT 1057
Amnesteem
ATRA
AT-RA
Atragen
Atra-IV
Atralin
Avita (TN)
Avita Gel
A-Vitaminsyre
A-Vitaminsyre [Denmark]
Avitoin
Avitoin [Norway]
BAL4079
beta all trans Retinoic acid
beta all trans Retinoic Acid
beta-all-trans-Retinoic acid
beta-Ra
beta-Retinoate
beta-Retinoic acid
beta-Retinoic Acid
Betarretin
BIDD:GT0483
BIDD:PXR0081
BML2-E05
bmse000562
BPBio1_000082
b-Retinoate
b-Retinoic acid
BRN 2057223
BSPBio_000074
BSPBio_001500
C00777
CCRIS 3294
CCRIS 7098
CHEBI:15367
CHEMBL38
CID444795
Claravis
Cordes vas
Cordes VAS [Germany]
CPD000058245
D00094
D014212
DB00523
DB00755
DB00982
Dermairol
Effederm
Effederm [France]
EINECS 206-129-0
Epi-aberel
EU-0101061
Eudyna
HMS1361K22
HMS1568D16
HMS1791K22
HMS1921D14
HMS1989K22
HMS2089D20
HMS2092N11
HMS502N05
HSDB 2169
|
HSDB 7186
I04-0008
I14-2351
IDI1_000903
IDI1_033970
Isotretinoin Retinoic acid
L000833
LGD 100057
LMPR01090019
Lopac0_001061
LS-1154
Lsotretinoin
MLS000028588
MLS001076515
MLS002207234
MLS002222211
MolPort-000-883-857
NCGC00017280-06
NCGC00017280-17
NCGC00021808-04
NCGC00021808-05
NCGC00021808-06
NCGC00021808-07
NCGC00021808-09
NCGC00021808-14
NCGC00021808-15
nchembio.154-comp2
Nexret
NSC 122758
NSC122758
NSC-122758
Panretin Gel
Panretyn
PDT-002-002
Potassium salt, tretinoin
Potassium Salt, Tretinoin
Prestwick_424
Prestwick2_000257
Prestwick3_000257
R 2625
R0064
R2625_SIGMA
REA
Renova
Renova (TN)
Retacnyl
Retin a
Retin A
Retin A (TN)
Retin-a
Retin-A
Retin-A Micro
Retinoate
Retinoic acid
RETINOIC ACID, ALL TRANS
Retinoic acid, all-trans- (8CI)
Retinova
Retionic acid
Retionic Acid
Retisol-a
Retisol-A
ro 1-5488
Ro 1-5488
S1653_Selleck
Salt, tretinoin potassium
Salt, Tretinoin Potassium
Salt, tretinoin sodium
Salt, Tretinoin Sodium
Salt, tretinoin zinc
Salt, Tretinoin Zinc
SAM002264647
SMR000058245
Sodium salt, tretinoin
Sodium Salt, Tretinoin
Solage
Sotret
SPECTRUM1502016
Spectrum5_001746
Spectrum5_001933
SR-01000000239
SR-01000000239-14
ST057075
Stieva-a
Stieva-A
Stieva-a Forte
trans Retinoic acid
trans Retinoic Acid
trans-Retinoate
trans-Retinoic acid
Tretin m
Tretin M
tretinoin
Tretinoin
Tretinoin (JAN/USP/INN)
Tretinoin (TN)
Tretinoin [USAN:INN:BAN]
Tretinoin 0.1% cream or placebo
tretinoin liposome
Tretinoin potassium salt
Tretinoin Potassium Salt
Tretinoin sodium salt
Tretinoin Sodium Salt
Tretinoin zinc salt
Tretinoin Zinc Salt
Tretinoin/All-Trans Retinoic Acid
Tretinoina
Tretinoina [INN-Spanish]
Tretinoine
Trétinoïne
tretinoine (French) (EINECS)
Tretinoine [INN-French]
Tretinoino
Tretinoino [INN-Spanish]
Tretinoinum
Tretinoinum [INN-Latin]
TRETINON
Tri-Luma
UNII-1UA8E65KDZ
UNII-5688UTC01R
UPCMLD-DP097
Vesanoid
Vesanoid (TN)
Vesanoid, Airol, Renova, Atralin, Retin-A, Avita, Tretinoin
Vesnaroid
Vitamin a acid
Vitamin A acid
Vitinoin
WLN: L6UTJ A1 B1U1Y1 & U2U1Y1 & U1VQ C1 C1
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U1VQ C1 C1
Zinc salt, tretinoin
Zinc Salt, Tretinoin
β-retinoate
β-retinoic acid
|
|
14 |
|
Choline |
Approved, Nutraceutical |
Phase 4 |
|
62-49-7 |
305 |
Synonyms:
(2-Hydroxyethyl)trimethyl ammonium
(2-Hydroxyethyl)trimethylammonium
(beta-Hydroxyethyl)trimethylammonium
2-Hydroxy-N,N,N-trimethylethanaminium
2-Hydroxy-N,N,N-trimethyl-ethanaminium
Bilineurine
Biocolina
Biocoline
Bitartrate, choline
Bursine
Chloride, choline
Choline bitartrate
Choline cation
Choline chloride
Choline citrate
Choline hydroxide
Choline ion
CHOLINE ion
Choline O sulfate
Choline O-sulfate
|
Cholinum
Citrate, choline
Fagine
Hepacholine
Hormocline
Hydroxide, choline
Lipotril
N,N,N-trimethylethanol-ammonium
N,N,N-Trimethylethanolammonium
N,N,N-Trimethylethanol-ammonium
Neocolina
N-trimethylethanolamine
N-Trimethylethanolamine
O-Sulfate, choline
Paresan
trimethylethanolamine
Trimethylethanolamine
Vidine
Vitamin J
|
|
15 |
|
Prednisolone hemisuccinate |
Experimental |
Phase 4 |
|
2920-86-7 |
|
Synonyms:
(+)-prednisolone hemisuccinate
Prednisolonbisuccinat
Prednisolone 21-hemisuccinate
Prednisolone 21-succinate
|
Prednisolone bisuccinate
Prednisolone hydrogen succinate
Prednisolone succinate
|
|
16 |
|
Methylprednisolone Acetate |
|
Phase 4 |
|
|
|
17 |
|
Cyclosporins |
|
Phase 4 |
|
|
|
18 |
|
Calcineurin Inhibitors |
|
Phase 4 |
|
|
|
19 |
|
Angiogenesis Inhibitors |
|
Phase 4 |
|
|
|
20 |
|
Alkylating Agents |
|
Phase 4 |
|
|
|
21 |
|
Laxatives |
|
Phase 4 |
|
|
|
22 |
|
Cathartics |
|
Phase 4 |
|
|
|
23 |
|
Carboxymethylcellulose Sodium |
|
Phase 4 |
|
|
|
24 |
|
Cytidine Diphosphate Choline |
|
Phase 4 |
|
|
|
25 |
|
Adrenocorticotropic Hormone |
|
Phase 4 |
|
|
|
26 |
|
Melanocyte-Stimulating Hormones |
|
Phase 4 |
|
|
|
27 |
|
beta-Endorphin |
|
Phase 4 |
|
|
|
28 |
|
Adalimumab |
Approved |
Phase 3 |
|
331731-18-1 |
16219006 |
Synonyms:
331731-18-1
Adalimumab
Adalimumab (genetical recombination)
Adalimumab (genetical recombination) (JAN)
Adalimumab (USAN/INN)
adalimumab-adaz
adalimumab-adbm
adalimumab-afzb
|
adalimumab-atto
adalimumab-bwwd
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
|
|
29 |
|
Phenylephrine |
Approved |
Phase 3 |
|
59-42-7 |
6041 |
Synonyms:
(-)-m-Hydroxy-a-(methylaminomethyl)benzyl alcohol
(-)-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol
(−)-m-hydroxy-α-(methylaminomethyl)benzyl alcohol
(-)-m-Hydroxy-α-(methylaminomethyl)benzyl alcohol
(R)-2-Hydroxy-2-(3-hydroxyphenyl)-N-methylethylamine
(R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol
1416-03-1
3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol
59-42-7
61-76-7 (hydrochloride)
AC1L1LO9
AC1Q40UF
Adrianol
Ah-Chew
AI3-02402
Ak-dilate
AK-Dilate
Ak-nefrin
AK-Nefrin
Alcon efrin
Alcon Efrin
Alconefrin nasal drops 12
Alconefrin Nasal Drops 12
Alconefrin nasal drops 25
Alconefrin Nasal Drops 25
Alconefrin nasal drops 50
Alconefrin Nasal Drops 50
Alconefrin nasal spray 25
Alconefrin Nasal Spray 25
Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (R)- (9CI)
BIDD:GT0157
Biomydrin
BSPBio_002420
C07441
CCRIS 8464
CHEBI:8093
CHEMBL1215
CID6041
Cyclomydril
D08365
DB00388
Dilatair
Dimetane
Dionephrine
DivK1c_000597
Doktors
Duration
EINECS 200-424-8
EINECS 215-810-1
Fenilefrina
Fenilefrina [INN-Spanish]
HSDB 3383
IDI1_000597
I-phrine
I-Phrine
Isophrim
Isophrin
isopto Frin
Isopto Frin
KBio1_000597
KBio2_001581
KBio2_004149
KBio2_006717
KBio3_001640
KBioGR_001313
KBioSS_001581
l-(3-Hydroxyphenyl)-N-methylethanolamine
L-(3-Hydroxyphenyl)-N-methylethanolamine
l-1-(m-Hydroxyphenyl)-2-methylaminoethanol
l-alpha-Hydroxy-beta-methylamino-3-hydroxy-L-ethylbenzene
l-m-Hydroxy-alpha-((methylamino)methyl)benzyl alcohol
Lopac0_000920
Lopac-P-6126
L-Phenylephedrine
L-Phenylephrine
LS-43027
Mesaton
Mesatone
Mesatonum
Metaoxedrin
Metaoxedrine
Metaoxedrinum
|
Metasympatol
Metasynephrine
Metsatonum
Mezaton
Minims phenylephrine
Minims Phenylephrine
m-Methylaminoethanolphenol
M-Methylaminoethanolphenol
MolPort-001-792-191
m-Oxedrine
M-Oxedrine
m-Sympathol
M-Sympathol
m-Sympatol
M-Sympatol
m-Synephrine
M-Synephrine
Mydfrin
NCGC00015825-01
NCGC00015825-02
NCGC00024257-03
NCGC00024257-05
NCGC00024257-06
neo Synephrine
Neofrin
Neophryn
neo-Synephrine
Neosynephrine
Neo-Synephrine
neo-Synephrine nasal drops
Neo-Synephrine Nasal Drops
neo-Synephrine nasal jelly
Neo-Synephrine Nasal Jelly
neo-Synephrine nasal spray
Neo-Synephrine Nasal Spray
neo-Synephrine pediatric nasal drops
NINDS_000597
Nostril
Nostril spray pump
Nostril Spray Pump
Nostril spray pump mild
Nostril Spray Pump Mild
Ocugestrin
Ocu-phrin sterile eye drops
Ocu-Phrin Sterile Eye Drops
Ocu-phrin sterile ophthalmic solution
P0395
PDSP1_001108
PDSP2_001092
Phenoptic
phenylephrine
Phenylephrine
Phenylephrine (INN)
Phenylephrine [INN:BAN]
Phenylephrine hydrochloride
Phenylephrine Minims
Phenylephrine Minims (TN)
Phenylephrine tannate
Phenylephrinum
Phenylephrinum [INN-Latin]
Prefrin
Prefrin liquifilm
Prefrin Liquifilm
Pyracort D
R(-)-Mezaton
R(-)-Phenylephrine
Relief eye drops for red eyes
Relief Eye Drops for Red Eyes
Rhinall
SPBio_001280
Spectrum_001101
Spectrum2_001280
Spectrum3_000770
Spectrum4_000967
Spectrum5_001411
Spersaphrine
Tannate, phenylephrine
Tannins, compds. with (R)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol
UNII-1WS297W6MV
Vicks sinex
Vicks Sinex
Visadron
|
|
30 |
|
Fluorometholone |
Approved, Investigational |
Phase 3 |
|
426-13-1 |
9878 |
Synonyms:
(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one
(6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11beta,17alpha-Dihydroxy-9-fluoro-6-methyl-1,4-pregnadiene-3,20-dione
426-13-1
9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione
9-fluoro-11b,17-Dihydroxy-6a-methylpregna-1,4-diene-3,20-dione
9-fluoro-11beta,17-Dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11-beta,17-dihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
9-fluoro-11β,17-dihydroxy-6α-methylpregna-1,4-diene-3,20-dione
AC1L1U0Y
AC-3520
AI3-52813
Alcon brand OF fluorometholone
Alcon Brand of Fluorometholone
Allergan brand 1 OF fluorometholone
Allergan Brand 1 of Fluorometholone
Allergan brand 2 OF fluorometholone
Allergan Brand 2 of Fluorometholone
Allergan brand 3 OF fluorometholone
Allergan Brand 3 of Fluorometholone
BPBio1_001029
BRD-K64862097-001-03-9
BSPBio_000935
CHEMBL1200600
CID9878
component of Neo-Oxylone
Cortilet
Cortisdin
D005469
D01367
DB00324
Delmeson
Efflumidex
EINECS 207-041-5
F0414
F9381_SIGMA
Fluaton
Flucon
Flucon, isopto
Flucon, Isopto
Flumetholon
Fluor Op
Fluor OP
Fluormetholon
Fluormetholone
Fluormetholonum
fluoro Ophtal
Fluoro Ophtal
Fluoromethalone
Fluorometholon
fluorometholone
Fluorometholone
Fluorométholone
Fluorometholone (JP15/USP/INN)
Fluorometholone [INN:BAN:JAN]
Fluorometholonum
Fluorometholonum [INN-Latin]
Fluorometolona
Fluorometolona [INN-Spanish]
|
Fluorometolone
Fluorometolone [DCIT]
fluoro-Ophtal
Fluoro-Ophtal
Fluor-Op
Fluor-OP
Fluor-op (TN)
Fluoropos
FML
Fml (TN)
FML Forte
FML Liquifilm
FML S.O.P
FML-S Liquifilm
HMS1570O17
Isdin brand OF fluorometholone
Isdin Brand of Fluorometholone
isopto Flucon
Isopto Flucon
Loticort
LS-118455
MLS000069537
MLS001076157
MolPort-003-941-413
NCGC00021575-03
NCI60_002886
Neo-Oxylone
Novartis brand OF fluorometholone
Novartis Brand of Fluorometholone
NSC 33001
NSC33001
NSC-33001
Oxylone
Oxylone (TN)
Pharm allergan brand OF fluorometholone
Pharm Allergan Brand of Fluorometholone
Pharm-allergan brand OF fluorometholone
Pharm-Allergan Brand of Fluorometholone
Pharmascience brand OF fluorometholone
Pharmascience Brand of Fluorometholone
PMS Fluorometholone
PMS-Fluorometholone
Pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,17
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17-dihydroxy-6alpha-methyl- (8CI)
Prestwick_227
Prestwick0_000718
Prestwick1_000718
Prestwick2_000718
Prestwick3_000718
SMR000058598
SPBio_002856
Trilcin
U 8614
UNII-SV0CSG527L
Ursapharm brand OF fluorometholone
Ursapharm Brand of Fluorometholone
Ursnon
Winzer brand OF fluorometholone
Winzer Brand of Fluorometholone
ZINC03876158
|
|
31 |
|
Oxymetazoline |
Approved, Investigational |
Phase 3 |
|
1491-59-4 |
4636 |
Synonyms:
1491-59-4
2-(4-tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline
2-(4-tert-Butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline
2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline
3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-6-tert-butyl-phenol
3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol
3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol
3-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol
6-t-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-tert-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-tert-Butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol
AC1L1IM1
AC-6370
Afrin Cherry 12 Hour Nasal Spray
Afrin Extra Moisturizing 12 Hour Nasal Spray
Afrin Original 12 Hour Nasal Spray
Afrin Original 12 Hour Nose Drops
Afrin Original 12 Hour Pump Mist
Afrin Sinus 12 Hour Nasal Spray
Biomol-NT_000161
BPBio1_000295
BPBio1_000419
BRD-K16195444-001-01-7
BRN 0886303
BSPBio_000267
BSPBio_002145
C07363
CAS-151615
CHEBI:142520
CHEMBL762
CID4636
D010109
D08322
DB00935
DivK1c_000567
Dristan Long Lasting Mentholated Nasal Spray
Dristan Long Lasting Nasal Mist
Drixoral Nasal Solution
Duramist Plus Up To 12 Hour Nasal Decongestant Spray
EINECS 216-079-1
FT-0082560
Genasal Nasal Spray Up to 12 Hour Relief
H 990
Hazol
HMS2089G03
HSDB 3143
Hydrochloride, oxymetazoline
IDI1_000567
Iliadin
KBio1_000567
KBio2_001531
KBio2_004099
KBio2_006667
KBio3_001645
KBioGR_000908
KBioSS_001531
L000459
Lopac0_000903
|
Lopac-O-2378
LS-104146
MolPort-002-538-313
Nafrine
Nasal Relief 12 Hour Nasal Spray
Navasin
Navisin
NCGC00015766-01
NCGC00015766-02
NCGC00015766-03
NCGC00015766-10
NCGC00022345-02
NCGC00022345-04
NCGC00022345-05
NCGC00022345-06
nchembio705-11
Neo-Synephrine 12 Hour Spray
Nezeril
NINDS_000567
Nostrilla 12 Hour Nasal Decongestant
Operil (TN)
Oximetazolina
Oximetazolina [INN-Spanish]
Oximetazolinum
Oxylazine
oxymeta zoline
Oxymetazolina
oxymetazoline
Oxymetazoline
Oxymétazoline
Oxymetazoline (INN)
Oxymetazoline [INN:BAN]
Oxymetazoline hydrochloride
oxymetazoline hydrochloride crystalline
Oxymetazoline hydrochloride crystalline
Oxymetazolinum
Oxymetazolinum [INN-Latin]
Oxymethazoline
Oxymetozoline
Phenol, 3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethyl- (9CI)
Phenol, 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl- (7CI,8CI)
Prestwick0_000224
Prestwick1_000224
Prestwick2_000224
Prestwick3_000224
Rhinofrenol
Rhinolitan
Sinerol
SPBio_001095
SPBio_002188
Spectrum_001051
Spectrum2_000998
Spectrum3_000533
Spectrum4_000464
Spectrum5_001114
Tocris-1142
UNII-8VLN5B44ZY
Vicks Sinex 12 Hour Nasal Spray
Vicks Sinex 12 Hour Ultra Fine Mist for Sinus Relief
Visine L.R
Visine L.R.
|
|
32 |
|
Rifampicin |
Approved |
Phase 3 |
|
13292-46-1 |
5381226 5458213 |
Synonyms:
13292-46-1
1-b]furan-21-yl acetate
3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV
3-(4-Methylpiperazinyliminomethyl)rifamycin SV
3-(4-Methylpiperazinyliminomethyl)-rifamycin SV
3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV
3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin
46713_FLUKA
46713_RIEDEL
62534-43-4
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
8-(4-Methylpiperazinyliminomethyl) rifamycin SV
8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin
8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv
8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv
83907_FLUKA
83907_SIGMA
8CI)
Abrifam
Archidyn
Arficin
Arzide
AZT + Rifampin
Ba 41166
Ba 41166/E
BA-41166E
Benemicin
Benemycin
BIDD:PXR0014
Bio-0621
BPBio1_000561
BSPBio_000509
C06688
C43H58N4O12
CAS-13292-46-1
CCRIS 551
CHEBI:28077
CHEBI:455936
CHEMBL180
CID5381226
CID5388984
CID5458213
CID5702112
CID6604339
CID6708473
CID6842115
CID6912767
CID6913622
CPD001906767
D00211
DB01045
Dione 21-acetate
Dipicin
DivK1c_000550
Doloresum
DRG-0109
EINECS 236-312-0
Eremfat
Famcin
Fenampicin
HMS1569J11
HMS1920P08
HMS2089F12
HMS2092G09
HMS501L12
HSDB 3181
KBio1_000550
KBio2_000919
KBio2_003487
KBio2_006055
KBio3_003018
KBioGR_001780
KBioSS_000919
L-5103
L-5103 Lepetit
LS-7689
MLS000028552
MLS001148237
MLS001333745
MolPort-000-767-051
MolPort-002-513-586
MolPort-003-666-281
MolPort-006-395-891
NCGC00016699-01
NCGC00017365-01
NCGC00018178-01
NCGC00022678-03
NCGC00022678-04
NCGC00022678-05
NCGC00160500-01
nchembio884-comp4
|
NCI60_000309
NINDS_000550
NSC 113926
NSC113926
NSC-113926
Piperine & Rifampicin
Prestwick_833
Prestwick0_000525
Prestwick1_000525
Prestwick2_000525
Prestwick3_000525
R/AMP
R0079
R3501_SIAL
R3501_SIGMA
R5777_SIGMA
R7382_SIGMA
Ramp
RAMP
R-Cin
Reserpine & Rifampicin
Rf
Rfamipicin
RFP
Rifa
Rifadin
Rifadin (TN)
Rifadin I.V
Rifadin I.V.
Rifadin Iv
Rifadin IV
Rifadin, Rimactane, Rifampicin, Rifampin
Rifadine
Rifagen
Rifaldazin
Rifaldazine
Rifaldin
Rifam
Rifamicin AMP
Rifamor
Rifampicin
Rifampicin & EEP
Rifampicin & Propolis
Rifampicin (JP15/INN)
Rifampicin [INN:BAN:JAN]
Rifampicin SV
Rifampicina
Rifampicina [INN-Spanish]
Rifampicine
Rifampicine [French]
Rifampicinum
Rifampicinum [INN-Latin]
rifampin
Rifampin
Rifampin (USP)
Rifampin [USAN]
Rifamsolin
Rifamycin
Rifamycin Amp
Rifamycin AMP
Rifaprodin
Rifcin
Rifinah
Rifobac
Rifoldin
Rifoldine
Riforal
Rimactan
Rimactane
Rimactane (TN)
Rimactazid
Rimactin
Rimactizid
Rimazid
Rimycin
RMP
Rofact
S1764_Selleck
SAM002264646
Sinerdol
SMR000058322
SMR000653525
SPBio_002430
Spectrum_000439
SPECTRUM1500529
Spectrum3_001837
Spectrum4_001250
Spectrum5_002018
STK080143
TNP00313
Tubocin
UNII-VJT6J7R4TR
WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1
|
|
33 |
|
Ethambutol |
Approved |
Phase 3 |
|
74-55-5 |
3279 14052 |
Synonyms:
(-)-(R,R)-2,2'-(1,2-Ethylenediimino)-di-1-butanol
(+)-(S,S)-2,2'-(1,2-Ethylenediimino)-di-1-butanol
(+)-2,2'-(ethylenediimino)di-1-butanol
(+)-2,2'-(ethylenediimino)Di-1-butanol
(+)-2,2'-(Ethylenediimino)di-1-butanol
(+)-ethambutol
(+)-Ethambutol
(+)-N,N'-bis(1-(hydroxymethyl)propyl)ethylenediamine
(+)-N,N'-Bis(1-(hydroxymethyl)propyl)ethylenediamine
(+)-S,S-ethambutol
(+)-S,S-Ethambutol
(2R)-2-[2-(1-hydroxybutan-2-ylamino)ethylamino]butan-1-ol
(2R)-2-[2-[[(2R)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol
(2'S)-2,2'-[Ethane-1,2-diyldi(imino)]dibutan-1-ol
(2S)-2-[2-(1-hydroxybutan-2-ylamino)ethylamino]butan-1-ol
(2S)-2-[2-[[(2R)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol
(2S)-2-[2-[[(2S)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol
(2S,2'S)-2,2'-(ethane-1,2-diyldiimino)dibutan-1-ol
(2S,7S)-2,7-diethyl-3,6-diazaoctane-1,8-diol
(2S,7S)-2,7-Diethyl-3,6-diazaoctane-1,8-diol
(R)-2,2'-(1,2-Ethanediyldiimino)bis-1-butanol
(S,R)-2,2'-(1,2-Ethylenediimino)-di-1-butanol
(S,S)-ethambutol
(S,S)-Ethambutol
1070-11-7
2,2'-(1,2-Ethylenediimino)-di-1-butanol
2,2'-(ethane-1,2-diyldiimino)dibutan-1-ol
2-[2-(1-hydroxybutan-2-ylamino)ethylamino]butan-1-ol
74-55-5
75343-56-5
AC1L1FKQ
AC1L230T
AC1L9YT2
AC1LABPH
AC1LAKIP
AC1LAKIS
AC1Q2C85
AC1Q2SHV
AC1Q77PZ
Aethambutolum
AHP brand OF ethambutol hydrochloride
AR-1A7805
AR-1C2065
BPBio1_000105
BSPBio_000095
BSPBio_002012
C06984
C10H24N2O2
CAS-1070-11-7
CHEBI:4877
CHEMBL43824
CHEMBL44884
CID14052
CID3279
CID465436
CID470071
CID470072
CID504259
CL 40881 (dihydrochloride)
CPD000046147
d,N,N'-Bis(1-hydroxymethylpropyl)ethylenediamine
D07925
D-2,2'-(Ethylenediimino)bis(1-butanol)
D-2,2'-(Ethylenediimino)di-1-butanol
Dadibutol
DB00330
D-Ethambutol
Dexambutol
Diambutol
DivK1c_000561
D-N,N'-Bis(1-hydroxymethylpropyl)ethylenediamine
EINECS 200-810-6
Elan brand OF ethambutol hydrochloride
EMB
EMB fatol
EMB hefa
EMB-fatol
EMB-hefa
|
Etambutol
Etambutol [INN-Spanish]
Etambutol llorente
Etambutolo
Etambutolo [DCIT]
ethambutol
Ethambutol
Ethambutol & EEP
Ethambutol & Propolis
Ethambutol (INN)
Ethambutol [INN:BAN]
Ethambutol dihydrochloride
Ethambutol HCL
Ethambutol hydrochloride
Ethambutol Hydrochloride
Ethambutol, (-)-isomer
Ethambutol, meso form
Ethambutol, racemic mixture
Ethambutolum
Ethambutolum [INN-Latin]
Etibi
Fatol brand OF ethambutol hydrochloride
Genopharm brand OF ethambutol hydrochloride
HSDB 3078
Hydrochloride, ethambutol
ICN brand OF ethambutol hydrochloride
IDI1_000561
KBio1_000561
KBio2_001538
KBio2_004106
KBio2_006674
KBio3_001232
KBioGR_001209
KBioSS_001538
KST-1A8084
Lederle brand OF ethambutol hydrochloride
Llorente brand OF ethambutol hydrochloride
Llorente, etambutol
LS-187119
LS-46537
Miambutol
MLS000082702
MolPort-002-507-956
MolPort-003-847-110
Myambutol
Myambutol (dihydrochloride)
NCGC00016560-01
NCGC00178864-01
NCGC00179661-01
NINDS_000561
NSC653313
Prestwick0_000028
Prestwick1_000028
Prestwick2_000028
Prestwick3_000028
Purderal
Riemser brand OF ethambutol hydrochloride
S,S-Ethambutol
SAM002589988
Sanavita brand OF ethambutol hydrochloride
SERB brand OF ethambutol hydrochloride
Servambutol
Servambutol (TN)
SMR000046147
SPBio_001167
SPBio_002016
Spectrum_001058
Spectrum2_001014
Spectrum3_000426
Spectrum4_000545
Spectrum5_000702
STK711105
STOCK5S-98432
Tibutol
UNII-8G167061QZ
Wernigerode brand OF ethambutol hydrochloride
Wyeth brand OF ethambutol hydrochloride
|
|
34 |
|
Dipivefrin |
Approved |
Phase 3 |
|
52365-63-6 |
3105 |
Synonyms:
( -)-2,2-Dimethylpropansaeure-4-(1-hydroxy-2-(methylamino)ethyl)-1,2-phenylenester
( -)-4-(1-Hydroxy-2-methylaminoethyl)-o-phenylendipivalat
(+-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol 3,4-dipivalate
(+-)-4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate
(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate
(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalic acid
(±)-4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate
(RS)-4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-phenylen dipivalat
[2-(2,2-dimethylpropanoyloxy)-4-[1-hydroxy-2-(methylamino)ethyl]phenyl] 2,2-dimethylpropanoate
1-(3',4'-dipivaloyloxyphenyl)-2-methylamino-1-ethanol
1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol
2,2-Dimethylpropanoic acid 4-[1-hydroxy-2-(methylamino)ethyl]-1,2-phenylene ester
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-phenylen dipivalat
4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diyl bis(2,2-dimethylpropanoate)
4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate
4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate
4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalic acid
52365-63-6
AB00514686
AC1L1F6K
Adrenaline dipivalate
AKOS003662293
AKPro
Alcon brand OF dipivefrin hydrochloride
Allergan brand OF dipivefrin hydrochloride
apo-Dipivefrin
Apotex brand OF dipivefrin hydrochloride
BPBio1_000688
BRD-A47494775-003-03-0
BSPBio_000624
C06963
C19H29NO5
CHEBI:4646
CID3105
D Epifrin
D02349
DB00449
Diopine
Dipivaloylepinephrine
dipivalyl epinephrine
Dipivalyl epinephrine
dipivefrin
Dipivefrin
Dipivefrin (USAN)
|
Dipivefrin [USAN]
Dipivefrin acetate, (+-)-isomer
Dipivefrin citrate (1:1), (+-)-isomer
Dipivefrin HCL
Dipivefrin hydrochloride
Dipivefrin hydrochloride, (+-)-isomer
Dipivefrin monophosphate, (+-)-isomer
Dipivefrin monosulfate, (+-)-isomer
Dipivefrin nitrate, (+-)-isomer
Dipivefrin perchlorate
Dipivefrin propanoate, (+-)-isomer
Dipivefrin tartrate (1:1), (+-)-(R-(r*,r*))-isomer
Dipivefrin tartrate (1:1), (R)-(R-(r*,r*))-isomer
Dipivefrin, (R)-isomer
Dipivefrina
Dipivefrina [INN-Spanish]
Dipivefrine
Dipivéfrine
Dipivefrine (INN)
Dipivefrinum
Dipivefrinum [INN-Latin]
Dipoquin
Glaucothil
Glaudrops
Ioquin brand OF dipivefrin hydrochloride
K 30081
L000915
LS-121419
NCGC00179499-01
nchembio747-comp3
Ophtho-Dipivefrin
Pharm-allergan brand OF dipivefrin hydrochloride
Pharmascience brand OF dipivefrin hydrochloride
PMS-Dipivefrin
Prestwick0_000632
Prestwick1_000632
Prestwick2_000632
Prestwick3_000632
Propine
Propine C Cap B.I.D.
ratio-Dipivefrin
Ratiopharm brand OF dipivefrin hydrochloride
SPBio_002843
UNII-8Q1PVL543G
|
|
35 |
|
Pyrazinamide |
Approved, Investigational |
Phase 3 |
|
98-96-4 |
1046 |
Synonyms:
2-carbamyl pyrazine
2-carbamylpyrazine
2-Carbamylpyrazine
2-pyrazinecarboxamide
2-Pyrazinecarboxamide
5-25-04-00178 (Beilstein Handbook Reference)
82612_FLUKA
98-96-4
AB00052083
AC1L1ALT
AC1Q4ZGM
AC-907/25014068
AKOS000120280
Aldinamid
Aldinamide
AZT + Pyrazinamide combination
BB_SC-1250
BIDD:GT0228
BPBio1_000515
Braccopiral
BRN 0112306
BSPBio_000467
BSPBio_002572
C01956
C5H5N3O
CAS- 98-96-4
CCRIS 545
CHEBI:45285
CHEMBL614
CID1046
Corsazinmid
CPD000036662
D00144
D011718
D-50
D-50 (VAN)
DB00339
Dipimide
DivK1c_000241
DRG 0124
EINECS 202-717-6
Eprazin
EU-0101011
Farmizina
HMS1569H09
HMS1920N08
HMS2092E09
HMS500M03
HSDB 3576
I14-6758
IDI1_000241
InChI=1/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9
Isopas
KBio1_000241
KBio2_001382
KBio2_003950
KBio2_006518
KBio3_001792
KBioGR_001851
KBioSS_001382
Lopac0_001011
Lopac-P-7136
LS-2053
Lynamide
MK 56
MLS000069730
MLS002222347
MolPort-001-770-770
NCGC00015833-01
NCGC00015833-02
NCGC00015833-05
NCGC00015833-10
NCGC00090695-01
NCGC00090695-03
NCGC00090695-04
NCGC00090695-05
NCGC00090695-06
NCGC00090695-07
NCI-C01785
|
NINDS_000241
Novamid
NSC 14911
NSC14911
P 7136
P ezetamid
P0633
P7136_SIGMA
Pezetamid
Pharozinamide
Piraldina
Pirazimida
Pirazinamid
Pirazinamida
Pirazinamida [INN-Spanish]
Pirazinamide
Pirazinamide [DCIT]
Pirilene
pms-Pyrazinamide
Prazina
Prestwick_811
Prestwick0_000514
Prestwick1_000514
Prestwick2_000514
Prestwick3_000514
Pyrafat
Pyramide
Pyrazide
Pyrazinamdie
Pyrazinamid
Pyrazinamida
pyrazinamide
Pyrazinamide
Pyrazinamide (JP15/USP/INN)
Pyrazinamide (TN)
Pyrazinamide [INN:BAN:JAN]
Pyrazinamide BP 2000
Pyrazinamidum
Pyrazinamidum [INN-Latin]
Pyrazine carboxamide
pyrazine carboxylamide
Pyrazine carboxylamide
pyrazine-2-carboxamide
PYRAZINE-2-carboxamide
Pyrazineamide
pyrazinecarboxamide
Pyrazinecarboxamide
Pyrazinecarboxylic acid amide
Pyrazinoate amide
Pyrazinoic acid am ide
pyrazinoic acid amide
Pyrazinoic acid amide
Pyrazinoic acid amide, Pezetamid, Pyrafat, Zinamide, Tebrazid, Pyrafat, Pyrazinamide
Pyrizinamide
PZA
Rifater
Rozide
S1762_Selleck
SAM002554927
SMR000036662
SPBio_001369
SPBio_002388
Spectrum_000902
SPECTRUM1500518
Spectrum2_001305
Spectrum3_001046
Spectrum4_001186
Spectrum5_001026
STK801661
T 165
Tebrazid
Tebrazio
Tisamid
UNII-2KNI5N06TI
Unipyranamide
WLN: T6N DNJ BVZ
Zinamide
Zinastat
ZINC00002005
|
|
36 |
|
Tropicamide |
Approved, Investigational |
Phase 3 |
|
1508-75-4 |
5593 |
Synonyms:
(+-)-N-Ethyl-2-phenyl-N-(4-pyridylmethyl)hydracrylamide
1508-75-4
5-22-09-00359 (Beilstein Handbook Reference)
AB00052120
AC1L1KOZ
AC1Q5IFA
AC-816
Akorn brand OF tropicamide
Akorn Brand of Tropicamide
Alcon brand OF tropicamide
Alcon Brand of Tropicamide
AR-1K6980
Bio-0810
Bistropamide
Bournonville brand OF tropicamide
Bournonville Brand of Tropicamide
BPBio1_000303
BRD-A79672927-001-05-8
BRN 0285563
BSPBio_000275
BSPBio_002289
Cahill may roberts brand OF tropicamide
Cahill May Roberts Brand of Tropicamide
Chauvin brand OF tropicamide
Chauvin Brand of Tropicamide
CHEMBL1200604
CID5593
Colircusi tropicamida
Colircusi Tropicamida
CPD000058523
D00397
D014331
DB00809
DivK1c_000448
EINECS 216-140-2
Epitromina
EU-0101223
HMS1568N17
HMS1921I09
HMS2089M05
HMS2092A18
HMS501G10
I06-0811
IDI1_000448
I-Picamide
KBio1_000448
KBio2_001064
KBio2_003632
KBio2_006200
KBio3_001509
KBioGR_000873
KBioSS_001064
L001262
Lopac0_001223
LS-28545
Medical ophthalmics brand OF tropicamide
Medical Ophthalmics Brand of Tropicamide
Minims tropicamide
MLS001306442
MLS002154240
MolPort-000-159-321
Mydral
Mydriacyl
Mydriacyl (TN)
Mydriafair
Mydriaticum
Mydrum
NCGC00016065-03
NCGC00016065-08
NCGC00024866-02
NCGC00024866-03
NCGC00024866-04
NCGC00024866-05
NCGC00024866-06
N-Ethyl-2-phenyl-N-(4-pyridylmethyl)hydracrylamide
N-Ethyl-2-phenyl-N-4-[-pyridyl-methyl]hydracrylamide
N-ethyl-3-hydroxy-2-phenyl-N-(pyridin-4-ylmethyl)propanamide
N-Ethyl-alpha-(hydroxymethyl)-N-(4-pyridinylmethyl)benzeneacetamide
N-Ethyl-N-(4-pyridylmethyl)tropamid
N-Ethyl-N-(4-pyridylmethyl)tropamide
n-ethyl-n-(g-picolyl)tropamide
NINDS_000448
Novartis brand OF tropicamide
Novartis Brand of Tropicamide
|
Ocu tropic
Ocu Tropic
Ocumed brand OF tropicamide
Ocumed Brand of Tropicamide
Ocusoft brand OF tropicamide
Ocusoft Brand of Tropicamide
Ocu-tropic
OcuTropic
Ocu-Tropic
Opticyl
Paremyd
Pharmafair brand OF tropicamide
Pharmafair Brand of Tropicamide
Prestwick_487
Prestwick0_000228
Prestwick1_000228
Prestwick2_000228
Prestwick3_000228
Rivex brand OF tropicamide
Rivex Brand of Tropicamide
Ro 1-7683
SAM002564235
SMP1_000304
SMR000058523
SPBio_000872
SPBio_002196
Spectro-Cyl
Spectrum_000584
SPECTRUM1500599
Spectrum2_000936
Spectrum3_000655
Spectrum4_000377
Spectrum5_001585
STK934612
Stulln brand 1 OF tropicamide
Stulln Brand 1 of Tropicamide
Stulln brand 2 OF tropicamide
Stulln Brand 2 of Tropicamide
T 9778
T9778_SIGMA
TL8001101
Triaminic DM
Tropicacyl
Tropicamid
Tropicamida
Tropicamida [INN-Spanish]
tropicamide
Tropicamide
Tropicamide (JP15/USP/INN)
Tropicamide [USAN:INN:BANJAN]
Tropicamide alcon brand
Tropicamide Alcon Brand
Tropicamide chauvin brand
Tropicamide Chauvin Brand
Tropicamide faure
Tropicamide Faure
Tropicamide minims
Tropicamide Minims
Tropicamide monofree
Tropicamide Monofree
Tropicamide monohydrochloride, (R)-isomer
Tropicamide Monohydrochloride, (R)-Isomer
Tropicamide monohydrochloride, (S)-isomer
Tropicamide Monohydrochloride, (S)-Isomer
Tropicamide novartis brand
Tropicamide Novartis Brand
Tropicamide ocumed brand
Tropicamide Ocumed Brand
Tropicamide pharmafair brand
Tropicamide Pharmafair Brand
Tropicamide rivex brand
Tropicamide Rivex Brand
Tropicamide, (+-)-isomer
Tropicamide, (+-)-Isomer
Tropicamide, (R)-isomer
Tropicamide, (R)-Isomer
Tropicamide, (S)-isomer
Tropicamide, (S)-Isomer
Tropicamidum
Tropicamidum [INN-Latin]
Tropikamid
Tropimil
UNII-N0A3Z5XTC6
Visumidriatic
|
|
37 |
|
Atropine |
Approved, Vet_approved |
Phase 3 |
|
51-55-8, 5908-99-6 |
174174 |
Synonyms:
(+-)-atropine
(+-)-Atropine
(+-)-hyoscyamine
(+-)-Hyoscyamine
(+,-)-Tropyl tropate
(+,-)-Tropyl tropic acid
(+/-)-Atropine
(+/-)-Hyoscyamine
(±)-atropine
(±)-hyoscyamine
(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2S)-3-hydroxy-2-phenylpropanoate
(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate
(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate
(3-endo)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate
(3-endo)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropic acid
(3-endo)-8-methyl-8-azabicyclo[3.2.1]octan-3-ol
(3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-azoniabicyclo[3.2.1]octane
(3-exo)-8-methyl-8-azabicyclo[3.2.1]octan-3-ol
[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate
[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate
[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoic acid
120-29-6
1alphaH,5alphaH-Tropan-3alpha-ol
1alphaH,5alphaH-Tropan-3alpha-ol (+-)-tropate (ester)
1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester)
1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester) (8CI)
1alphaH,5alphaH-Tropan-3beta-ol
2-Phenylhydracrylic acid 3-alpha-tropanyl ester
51-55-8
8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate
8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoic acid
8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate
8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropic acid
8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropionate
A0132_SIGMA
A2468_SIGMA
AC1L5AX3
AC1Q3XL2
ACon1_000046
AI3-60219
AKOS005137976
Ambap120-29-6
Anaspaz
Atropair
Atropen
Atropen (TN)
Atropin
Atropin [German]
Atropina
Atropina [Italian]
a-Tropine
Atropine
ATROPINE
Atropine (USP)
Atropine [BAN]
Atropine Care
Atropine sulfate
Atropine Sulfate S.O.P.
Atropin-flexiolen
atropinium cation
atropinium(1+)
Atropinol
Atropinum
Atropt
Atrosulf
b eta-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
Belladenal
Bellergal-S
Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester
beta-Phenyl-gamma-oxypropionsaeure-tropyl-ester [German]
beta-Phenyl-gamma-oxypropionsaure-tropyl-ester [German]
bmse000649
BRD-A27290375-001-01-8
|
C01479
C17H23NO3
CAS-120-29-6
CCRIS 3080
CHEBI:15742
CHEBI:15884
CHEBI:16684
CHEBI:537621
CHEBI:57858
CHEMBL1235490
CID174174
CPD001906768
Cytospaz
D00113
d1-hyoscyamine
DB00572
DB04026
dl-Hyoscyamine
DL-Hyoscyamine
DL-Tropanyl 2-hydroxy-1-phenylpropionate
DL-Tropyl tropate
dl-tropyltropate
dl-Tropyltropate
DL-Tropyltropate
DL-Tropyltropic acid
EINECS 200-104-8
endo-(+/-)-alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
endo-8-methyl-8-azabicyclo[3.2.1]octan-3-ol
Eyesules
FT-0082634
HMS2089A16
HSDB 2199
hyoscyamine
Hyoscyamine sulfate
Isopto Atropine
Isopto-atropine
I-Tropine
LS-7203
MEGxp0_001878
Minims
Minims Atropine
MLS000069795
MLS001148094
MLS002695888
MolPort-001-742-593
MolPort-003-986-158
NCGC00016370-01
NCGC00142514-01
NCGC00142514-03
nchembio.307-comp21
Neo-Diophen
NP-010662
Ocu-Tropine
OR22908
Protamine & Atropine
SAM002554885
SMR000058248
ST057178
ST057655
T0534
TL8000018
tropan-3alpha-ol
tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate
tropan-3beta-ol
Tropanol
Tropic acid, 3-alpha-tropanyl ester
Tropic acid, ester with tropine
Tropine (+/-)-tropate
Tropine tropate
Tropine tropic acid
Tropine, tropate (ester)
Troyl tropate
Urised
|
|
38 |
|
Isoniazid |
Approved, Investigational |
Phase 3 |
|
54-85-3 |
3767 |
Synonyms:
37271-10-6
41466-07-3
4-pyridinecarbohydrazide
4-Pyridinecarbohydrazide
5015 R.P
5015 R.P.
5015 RP
54-85-3
62229-51-0
7640-37-1
AB00052025
Abdizide
AC1L1GNZ
AC1Q54UP
AC1Q54UQ
Acid vanillylidenehydrazide, isonicotinic
AI3-23936
AKOS000119062
Andrazide
Anidrasona
Antimicina
Antituberkulosum
Armacide
Armazid
Armazide
Atcotibine
AZT + Isoniazid
Azuren
bacillen
Bacillin
BB_SC-6246
BIDD:GT0140
Biomol-NT_000288
bp 5 015
BP 5015
BPBio1_000025
BPBio1_001322
BSPBio_000021
BSPBio_002204
C07054
C6H7N3O
CAS-54-85-3
CCRIS 351
Cedin
Cedin (Aerosol)
Cemidon
CHEBI:6030
CHEMBL64
Chemiazid
Chemidon
CID3767
Continazine
Cortinazine
Cotinazin
Cotinizin
CPD000059082
D00346
D007538
DB00951
Defonin
Dibutin
Diforin
Dinacrin
Ditubin
DivK1c_000070
Dow-Isoniazid
Ebidene
EINECS 200-214-6
Eralon
Ertuban
Eutizon
Evalon
Fetefu
Fimalene
FRS-3
FSR 3
FSR-3
Ftivazide
GINK
HIA
Hid rasonil
Hidranizil
Hidrasonil
Hidrulta
Hidrun
HMS1568B03
HMS1920H09
HMS2089I16
HMS2091N19
HMS500D12
HSDB 1647
Hycozid
Hydra
Hydrazid
Hydrazide
Hydrazide, isonicotinic acid
Hyozid
Hyzyd
I.A.I
I.A.I.
I0138
I14-9731
I3377_FLUKA
I3377_SIGMA
IDI1_000070
Ido-tebin
Idrazil
In-73
Inah
INH
Inh-Burgthal
INHd20
Inizid
Iscotin
Isidrina
Ismazide
Isobicina
Isocid
Isocidene
isoco tin
Isocotin
Isohydrazide
Isokin
Isolyn
Isonerit
Isonex
Isoniacid
isoniazid
Isoniazid
Isoniazid & EEP
Isoniazid & Propolis
Isoniazid SA
Isoniazida
Isoniazide
Isoniazidum
Isonicazide
Isonicid
Isonico
Isonicotan
Isonicotil
Isonicotinate hydrazide
Isonicotinhydrazid
Isonicotinic acid hydrazide
Isonicotinic acid vanillylidenehydrazide
Isonicotinic hydrazide
Isonicotinohydrazide
Isonicotinoyl hydrazide
Isonicotinoylhydrazide
Isonicotinsaeurehydrazid
Isonicotinsäurehydrazid
Isonicotinyl hydrazide
Isonicotinyl hydrazine
Isonicotinylhydrazine
Isonide
Isonidrin
Isonikazid
Isonilex
Isonin
Isonindon
Isonirit
|
Isoniton
Isonizida
Isonizide
Isopyrin
Isotamine
Isotebe
Isotebezid
Isotinyl
Isozid
isozid e
Isozide
Isozyd
KBio1_000070
KBio2_001333
KBio2_003901
KBio2_006469
KBio3_001424
KBioGR_000423
KBioSS_001333
L 1945
Laniazid
Laniazid (TN)
Laniozid
LANIZID
LS-205
MLS000069444
MLS001055327
MolPort-000-141-557
Mybasan
NCGC00016244-01
NCGC00016244-02
NCGC00022648-03
NCGC00022648-04
NCGC00022648-05
NCGC00022648-06
nchembio884-comp3
Neoteben
Neo-Tizide
Neoxin
Neumandin
Nevin
Niadrin
Nicazide
Nicetal
Nicizina
Niconyl
Nicotibina
Nicotibine
Nicotisan
Nicozide
Nidaton
nidra zid
Nidrazid
Nikozid
NINDS_000070
Niplen
Nitadon
Niteban
Nitebannsc 9659
NSC 9659
NSC9659
Nydrazid
Nyscozid
Oprea1_396155
Pelazid
Percin
Phthisen
Phthivazid
Phthivazide
Preparation 6424
Prestwick_578
Prestwick0_000161
Prestwick1_000161
Prestwick2_000161
Prestwick3_000161
Pycazide
Pyreazid
Pyricidin
Pyridicin
Pyridine-4-carboxylate hydrazide
Pyridine-4-carboxylic acid hydrazide
Pyrizidin
Raumanon
Razide
Retozide
Rifamate
Rimicid
rimif on
Rimifon
Rimiphone
Rimitsid
Robiselin
Robisellin
Roxifen
RP 5015
RP-5015
RU-EF-Tb
RY-EF-Tb
S1937_Selleck
SAM002554904
Sanohidrazina
Sauterazid
Sauterzid
SMR000059082
SPBio_000094
SPBio_001942
Spectrum_000853
SPECTRUM1500355
Spectrum2_000107
Spectrum3_000472
Spectrum4_000022
Spectrum5_000876
Stanozide
STK086288
TB-Phlogin
TB-Razide
TB-Vis
Tebecid
tebemid
Tebenic
Tebexin
Tebilon
Tebos
Teebaconin
Tekazin
Tibazide
Tibemid
Tibiazide
Tibinide
Tibison
Tibivis
Tibizide
Tibusan
Tisin
Tisiodrazida
Tizide
Tubazid
Tubazide
Tubeco
Tubecotubercid
tubercid
Tuberian
Tubicon
Tubilysin
Tubizid
Tubomel
Tyvid
Unicocyde
Unicozyde
UNII-V83O1VOZ8L
Usaf cb-2
Vanillylidenehydrazide, isonicotinic acid
Vazadrine
Vederon
WLN: T6NJ DVMZ
Zidafimia
Zinadon
ZINC00001590
Zonazide
|
|
39 |
|
Interferon alpha-2 |
|
Phase 3 |
|
|
|
40 |
|
interferons |
|
Phase 3 |
|
|
|
41 |
|
Interferon-alpha |
|
Phase 3 |
|
|
|
42 |
|
Antiviral Agents |
|
Phase 3 |
|
|
|
43 |
|
Anti-Infective Agents |
|
Phase 3 |
|
|
|
44 |
|
Antitubercular Agents |
|
Phase 3 |
|
|
|
45 |
|
Anti-Bacterial Agents |
|
Phase 3 |
|
|
|
46 |
|
Ophthalmic Solutions |
|
Phase 3 |
|
|
|
47 |
|
Mydriatics |
|
Phase 3 |
|
|
|
48 |
|
Isoniazid, pyrazinamide, rifampin drug combination |
|
Phase 3 |
|
|
|
49 |
|
Immunoglobulins |
|
Phase 3 |
|
|
|
50 |
|
Antibodies |
|
Phase 3 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 96)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
The Efficacy of Intravenous Pulses of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease, a Double Blind Pilot Study |
Unknown status |
NCT01306955 |
Phase 4 |
methylorednisolone |
2 |
A Multi-Center, Prospective Single Arm Study to Assess the Efficacy and Safety of RETISERT (Intravitreal Flucinolone Acetonide 0.59mg) in Patients With Refractory Ocular Behcet's Disease |
Unknown status |
NCT00720928 |
Phase 4 |
flucinolone acetonide |
3 |
Proof of Concept Study of the Effectiveness of Ozurdex in Lieu of Oral Corticosteroids for the Control of Active Intermediate and Posterior Uveitis Requiring Immunosuppressive Drug Therapy |
Completed |
NCT02049476 |
Phase 4 |
Dexamethasone pellet |
4 |
Multicenter Uveitis Steroid Treatment (MUST) Trial |
Completed |
NCT00132691 |
Phase 4 |
fluocinolone acetonide intraocular implant;oral corticosteroid with immunosuppressive agents as needed |
5 |
Prospective Open Label Study of H.P. Acthar Gel Injection in Patients With Active Non-Infectious Uveitis With Associated Glaucoma Thus High Frequency Regional Corticosteroid and Oral Corticosteroids Cause Intolerable Side-Effects |
Completed |
NCT02764697 |
Phase 4 |
H.P. ACTHAR SUBCUTANEOUS GEL INJECTION |
6 |
The Effects of BAK on the Blood Aqueous Barrier of Pseudophakic Patients |
Completed |
NCT01280110 |
Phase 4 |
Hydroxypropylmethylcellulose;Carboxymethylcellulose |
7 |
TAHOE: Sustained InTravitreal DexAmetHasone Implant (Ozurdex) for Uveitic Macular Edema |
Completed |
NCT01870440 |
Phase 4 |
Ozurdex Intravitreal Injection (0.7 mg) |
8 |
A Study to Investigate the Safety and Efficacy of Lucentis (Ranibizumab) in Patients With CNV Due to Causes Other Than AMD and in Patients Where Pigment Epithelial Detachments Are the Primary Manifestation of Their AMD. |
Completed |
NCT01628354 |
Phase 4 |
Ranibizumab |
9 |
Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) : Pattern Electroretinography Study |
Completed |
NCT03046693 |
Phase 4 |
Group A Citicoline 1000 mg oral tablet;Group B placebo oral tablet |
10 |
Open-label, Single-center, Prospective Study on the Efficacy and Safety of Repository Corticotropin Injection (H.P. ACTHAR GEL) in the Treatment of Adults With Non-infectious Retinal Vasculitis |
Recruiting |
NCT03066869 |
Phase 4 |
H.P. ACTHAR GEL |
11 |
A Multicenter, Open Label Pilot Study to Explore the Efficacy and Safety of Acthar Gel in Subjects With Severe Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis (NIPPU) |
Suspended |
NCT03656692 |
Phase 4 |
Acthar Gel |
12 |
Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema (CME) |
Withdrawn |
NCT02598869 |
Phase 4 |
Triamcinolone Acetonide |
13 |
A Multi-center, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye |
Unknown status |
NCT02746991 |
Phase 3 |
Sham Injection;FAI Insert |
14 |
A Double-Masked, Placebo-Controlled, Multi-Center, Parallel-Group, Dose-Ranging Study With an Optional Extension to Assess the Efficacy and Safety of LX211 as Therapy in Subjects With Clinically Quiescent Sight Threatening, Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis |
Completed |
NCT00404742 |
Phase 3 |
Placebo;LX211;LX211;LX211 |
15 |
A Double-Masked, Placebo-Controlled, Parallel Group, Multi-Center, Dose-Ranging Study With an Optional Extension to Assess the Efficacy and Safety of LX211 as Therapy in Subjects With Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis |
Completed |
NCT00404612 |
Phase 3 |
Placebo;LX211;LX211;LX211 |
16 |
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis |
Completed |
NCT00333814 |
Phase 2, Phase 3 |
Dexamethasone;dexamethasone;Sham injection |
17 |
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis - Including a Sub-study in Japanese Patients |
Completed |
NCT01124838 |
Phase 3 |
Adalimumab;Prednisone;Placebo |
18 |
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis |
Completed |
NCT03097315 |
Phase 3 |
|
19 |
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis |
Completed |
NCT01148225 |
Phase 3 |
adalimumab |
20 |
A Multicenter, Randomized, Double-Masked, Controlled Study to Evaluate the Safety & Efficacy of Intravitreal Fluocinolone Acetonide (0.59 or 2.1 mg) Implant in Subjects With Non-Infectious Uveitis Affecting the Posterior Segment of the Eye |
Completed |
NCT00407082 |
Phase 2, Phase 3 |
fluocinolone acetonide intravitreal implant;Fluocinolone acetonide 2.1mg |
21 |
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis - Including a Sub-study in Japanese Patients |
Completed |
NCT01138657 |
Phase 3 |
Prednisone;Placebo |
22 |
A Phase 3, Randomized, Masked, Controlled Clinical Trial to Study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for the Treatment of Subjects With Macular Edema Associated With Non-infectious Uveitis |
Completed |
NCT02595398 |
Phase 3 |
4mg CLS-TA Suprachoriodal Injection;Sham Procedure |
23 |
Phase III Study of Recombinant Human Interferon-alpha2a Versus Cyclosporin A for the Treatment of Ocular Behcet`s Disease - a National,Randomised, Single-masked Controlled Trial (INCYTOB) |
Completed |
NCT00167583 |
Phase 3 |
Cyclosporin A;Interferon-alpha2a |
24 |
A Phase III, Multinational, Multicenter, Randomized, Double-Masked, Study for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye |
Completed |
NCT01358266 |
Phase 3 |
DE-109 44 ug;DE-109 440 ug;DE-109 880 ug |
25 |
A 24 Week Multicenter, Randomized, Double-masked, Placebo Controlled Study to Assess the Difference in the Rate of Recurrent Exacerbations in Behçet¿s Patients With Posterior or Panuveitis Treated With AIN457 vs Placebo Adjunctive to Standard-of-care Immunosuppressive Therapy |
Completed |
NCT00995709 |
Phase 3 |
AIN457;AIN457;Placebo |
26 |
Intravitreal Bevacizumab for the Treatment of Neovascular Membranes in Patients With Intraocular Inflammation |
Completed |
NCT00407121 |
Phase 3 |
Bevacizumab |
27 |
Multicenter, Randomized Study Evaluating the Value of Antitubercular Treatment During Recurent Anterior Uveitis (URBA) |
Not yet recruiting |
NCT04117698 |
Phase 3 |
Antitubercular treatment (RIFATER ©);Ethambutol;RIFINAH © |
28 |
A Safety Open-label Study of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis Disease, an eXtension Study. The EYEGUARD-X Study |
Terminated |
NCT02375685 |
Phase 3 |
|
29 |
A 28-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study to Assess AIN457 Versus Placebo in Inducing and Maintaining Uveitis Suppression in Adults With Active, Non-infectious, Intermediate, Posterior or Panuveitis Requiring Immunosuppression (INSURE Study) |
Terminated |
NCT01095250 |
Phase 3 |
AIN457;AIN457;AIN457;Placebo |
30 |
An Open-Label, Non-Randomized, Single-Arm, Rollover Study to Continue Dosing of Gevokizumab in Subjects With Non Infectious Intermediate-, Posterior-, or Pan-Uveitis Patients Who Each Successfully Completed Either the X052130/CL3-78989-005 (EYEGUARDâ„¢-A) or the X052131/CL3-78989-006 (EYEGUARDâ„¢-C) Study or Who Have Controlled Ocular Inflammation After Receiving Study Drug in Study X052133 (EYEGUARDâ„¢-US) |
Terminated |
NCT02258854 |
Phase 3 |
Dose 2 gevokizumab |
31 |
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment |
Terminated |
NCT01747538 |
Phase 3 |
Placebo;Dose 1 gevokizumab;Dose 2 gevokizumab |
32 |
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis |
Terminated |
NCT01684345 |
Phase 3 |
Placebo;Dose 1 gevokizumab;Dose 2 gevokizumab |
33 |
A 24 Week Multi-center, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis. |
Terminated |
NCT01032915 |
Phase 3 |
Placebo |
34 |
A 34-week Extension to a 28-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study to Assess AIN457 Versus Placebo in Inducing and Maintaining Uveitis Suppression in Adults With Active, Non-infectious, Intermediate, Posterior, or Panuveitis Requiring Immunosuppression (INSURE Study) |
Terminated |
NCT01103024 |
Phase 3 |
|
35 |
A 38-week Extension to a 24-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis |
Terminated |
NCT01090310 |
Phase 3 |
AIN457;Placebo |
36 |
A Multicenter, Open-label Study to Evaluate the Long Term Clinical Use of Treatment With AIN457 in Patients Completing Clinical Trials Investigating AIN457 for the Treatment of Non-infectious Intermediate, Posterior or Panuveitis |
Withdrawn |
NCT01327664 |
Phase 3 |
|
37 |
Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study |
Unknown status |
NCT01717170 |
Phase 1, Phase 2 |
Tocilizumab |
38 |
A Multicenter, Single Sequence, Open-label Study to Assess the Tolerability, Safety, and Efficacy of 2 Weeks Oral AEB071 300 mg Twice Daily, Followed by 6 Weeks AEB071 200 mg Twice Daily in the Treatment of Patients With Macular Edema Associated With Non-infectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis |
Completed |
NCT00615693 |
Phase 2 |
AEB071 |
39 |
Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis |
Completed |
NCT01789320 |
Phase 1, Phase 2 |
triamcinolone acetonide (Triesence®) |
40 |
A Randomized, Masked, Multicenter Study to Assess the Safety and Efficacy of CLS-TA, Triamcinolone Acetonide Injectable Suspension in the Treatment of Subjects With Macular Edema Following Uveitis |
Completed |
NCT02255032 |
Phase 2 |
4 mg CLS-TA;0.8 mg CLS-TA |
41 |
Combination Daclizumab/Denileukin Diftitox (Ontak) Therapy for the Induction of Immune Tolerance in Non-infectious Intermediate and Posterior Uveitis |
Completed |
NCT00326508 |
Phase 2 |
Daclizumab |
42 |
A Randomized, Active-controlled, Open-label, Multicenter proof-of Concept Study of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, Posterior-, or Panuveitis Requiring Systemic Immunosuppressive Therapy |
Completed |
NCT01526889 |
Phase 2 |
LFG316;Conventional Therapy |
43 |
An Open-label Proof-of-concept Study With a Double-masked, Dose-ranging Component to Assess the Effects of AIN457 in Patients With Noninfectious Uveitis |
Completed |
NCT00685399 |
Phase 2 |
AIN457;AIN 457;AIN457 |
44 |
Research Study in Patients With Persistent Macular Edema Due to Diabetic Retinopathy, Retinal Vein Occlusion, Uveitis, or Irvine-Gass Syndrome |
Completed |
NCT00035906 |
Phase 2 |
DEX PS DDS® |
45 |
Evaluation of Birdshot RETINE CHOROIDOPATHY Treatment by Either Steroid or Interferon alpha2a |
Completed |
NCT00508040 |
Phase 2 |
interferon alpha 2a;prednisone |
46 |
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy With Intravitreal Injection of Lucentis (Ranibizumab Injection) |
Completed |
NCT00470977 |
Phase 1, Phase 2 |
ranibizumab injection (0.5 mg) |
47 |
Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study |
Completed |
NCT02620618 |
Phase 1, Phase 2 |
Intravitreal Infliximab |
48 |
Daclizumab for Active, Non-infectious, Sight-threatening Uveitis: A Phase II Pilot Study |
Completed |
NCT00070759 |
Phase 2 |
Daclizumab |
49 |
A Pilot Study to Investigate Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis |
Recruiting |
NCT02911116 |
Phase 2 |
Ustekinumab;Ustekinumab |
50 |
Sirolimus as a Therapeutic Approach for Uveitis: A Phase 2, Open-label, Randomized Study to Assess the Safety, Tolerability, and Bioactivity of Two Doses of Intravitreal Injection of Sirolimus in Patients With Non-infectious Uveitis |
Recruiting |
NCT01280669 |
Phase 2 |
Intravitreal injection 440mcg;Intravitreal injection of sirolimus 880mcg |
|